Postmenopausal Tuberculosis Endometritis by Güngördük, Kemal et al.
Hindawi Publishing Corporation
Infectious Diseases in Obstetrics and Gynecology
Volume 2007, Article ID 27028, 3 pages
doi:10.1155/2007/27028
CaseReport
Postmenopausal Tuberculosis Endometritis
Kemal G¨ ung¨ ord¨ uk, Volkan Ulker, Ahmet Sahbaz, Cemal Ark, and Alı Ismet Tekırdag
Department of Obstetrics and Gynecology, Gynecological Clinic, Istanbul Bakirkoy Women and Children Hospital, Istanbul, Turkey
Received 3 March 2007; Accepted 15 March 2007
Tuberculosis remains a global health problem, primarily in developing countries with inadequate health services. A signiﬁcant
portion of tuberculosis in these settings is extrapulmonary, including tuberculosis of the genitourinary tract. Patients with genital
tuberculosis are usually young women detected during work up for infertility. After menopause, tuberculosis of the endometrium
is a rare possibility probably because of the decreased vascularity of the tissues. We present a case of endometrial tuberculosis with
postmenopausal vaginal bleeding.
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1. INTRODUCTION
Morgani was the ﬁrst to describe genital tuberculosis in the
mid-eighteenth century and Tuberculous bacillus was discov-
ered in 1882 by Koch [1]. Tuberculosis (TB) of the genital
tractisalmostinvariablysecondarytodiseaseelsewhere,usu-
ally in the lungs. Five to 13% of patients with pulmonary TB
develop genital infection [1]. Female genital TB is a rare dis-
ease in some developed countries, but it is a frequent cause
of chronic pelvic inﬂammatory disease (PID) and infertility
in other parts of the world [2].
However, World Health Organization reported that tu-
berculosis was a global emergency in the early 1990s because
of the increased number of HIV-infected patients, increased
number of immigrants to the industrialized countries from
developing countries, and various social problems such as
poverty and homelessness [3].
The HIV pandemic poses major problems for the tu-
berculosis control program and for the individual clinicians
treating HIV-related tuberculosis. HIV-related immunosup-
pression is the single most potent risk factor for progression
from latent tuberculosis infection to active tuberculosis. As
a result, HIV is a major factor driving the global resurgence
of tuberculosis; incidence rates of tuberculosis in countries
with high prevalence of HIV infection have increased up to
ﬁve-fold [4].
The disease is responsible for 5% of all female pelvic in-
fections and occurs in 10% cases of pulmonary tuberculo-
sis. Although most of the aﬀected belong to reproductive age
group, the disease has been reported in postmenopausal fe-
m a l e sa sw e l l[ 5].
2. CASE
A 55-year-old postmenopausal woman, gravida 5 para 5,
menopausal for 3 years presented with irregular vaginal
bleeding for the past one month associated with passage of
clots.Therewasnopainatabdomen,foulsmellingdischarge,
fever, loss of weight, loss of appetite, or prior postcoital
bleeding. The patient was otherwise well and had no signif-
icant medical history. She had no personal or family history
of gynecological or other malignancy. She was not smoking
or had alcohol and substance abuse. She has never used oral
contraceptives or HRT. General physical and systemic exam-
ination detected no abnormality. On per speculum examina-
tion vagina was healthy and there was some bleeding from
the cervix. Uterus was anteverted, 8–10 weeks in size and bi-
lateral fornices free. Pap smear could not be performed be-
cause of vaginal bleeding. A Pap smear performed in another
clinic four months ago was normal.
Transvaginal pelvic ultrasound was performed and
showed an anteverted uterus with a grossly abnormal en-
dometrial echo pattern. The endometrium was heteroge-
nous and had an irregular surface (Figure 1). After the his-
tory and physical examination, endometrial biopsy was per-
formed with profuse, curettings obtained. Blood loss was
not excessive and the patient was discharged home the same
day. Histopathology of the curettings showed epithelioid cell
granulomas with Langhans giant cells (Figure 2).
The patient’s hepatitis and HIV status were negative.
All hematological and biochemical investigations were nor-
mal. PCR was performed on the formalin-ﬁxed paraﬃn-
embedded tissue for diagnosis of tuberculosis. PCR was2 Infectious Diseases in Obstetrics and Gynecology
Figure 1: Transvaginal pelvic ultrasound showed an abnormal en-
dometrial echo pattern. The endometrium was heterogenous and
had irregular surface.
Figure 2: A classical tuberculosus granuloma formed by epithelioid
macrophages, cuﬀed by lymhocytes and containing a Langhans gi-
ant cell (H&E×40).
positive for Mycobacterium tuberculosis in the endometrium.
Other tests for tuberculosis, namely, Mantoux was positive
at 32mm and ESR was 77mm. A chest X-ray showed mild
cardiomegaly but no evidence of pulmonary tuberculosis.
Thepatientreceivedantituberculosistreatment(4drugs:iso-
niazid, rifampicin, ethambutol, and pyrazinamide) for six
months and it has been learned that her bleeding ended in
the fourth week of her treatment. At subsequent follow-up
visits, patient is doing well and has been disease-free for 10
months.
3. DISCUSSION
Genital TB infection is usually caused by reactivation of
organisms from systemic distribution of Mycobacterium tu-
berculosisduringprimaryinfection.Itisestimatedthatabout
8 million new cases of tuberculosis infection occur each year
worldwide, and 95% of these cases are in undeveloped
countries. Tuberculosis primarily aﬀects the lungs, but about
one third of the patients also have involvement of extrapul-
monary organs such as the meninges, bones, skin, joints,
genitourinary tract, and abdominal cavity. Extrapulmonary
tuberculosis represents a progressively greater proportion
of new cases in the developed countries, and this trend is
still increasing [6, 7]. The resurgence of TB in the developed
world may be explained by the increased numbers of immi-
grants from areas where this disease is endemic as well as the
increasing prevalence of HIV infection with TB being one
of the opportunistic infections in individuals infected with
this virus [1]. People with latent tuberculosis infection are
at higher risk of progression to active disease if coinfected
with HIV, with the risk increasing to over 20 times that
in HIV-negative people as immunosuppression worsens.
HIV infection also causes recent tuberculosis infection to
progress more rapidly to disease [7, 8].
Direct transmission between sexual partners has been
documented. Spread from other intraperitoneal foci is rare
[7]. The fallopian tubes are aﬀected in almost 100% of the
cases followed by the endometrium in 50%, ovaries in 20%,
cervix in 5%, and vagina and vulva in <1% [1, 8]. Tubercu-
lous endometritis is almost invariably associated with tuber-
culous salpingitis except in the postmenopausal women, in
whom there may be no tubal disease [8].
Patients with genital tuberculosis are usually young
women during work up for infertility. Genital tuberculo-
sis is rare in postmenopausal women and responsible for
onlyapproximately1%ofpostmenopausalbleeding.Theen-
dometrium is aﬀected in 60–70%. The low incidence in the
postmenopausal age group is diﬃcult to explain. Most au-
thors believe that an atrophic endometrium oﬀers a poor
milieu for the growth of mycobacterium [9]. In a western
study of 475 cases of postmenopausal bleeding, no case of
tuberculosis was reported, while Indian studies report that
in women with genital tuberculosis, 1%–1.6% present with
postmenopausal bleeding [10].
Genital TB tends to be an indolent infection, disease may
not manifest for years after initial seeding. The most com-
mon presentations reported were infertility (44%), pelvic
pain(25%),vaginalbleeding(18%),amenorrhea(5%),vagi-
naldischarge(4%),andpostmenopausalbleeding(2%).Less
commonpresentationsincludedabdominalmass,ascites,tu-
boovarian abscess, and vague abdominal distention [11].
In a recent report of primary endometrioid adenocar-
cinoma coexisting with endometrial tuberculosis and tubal
adenocarcinoma coexisting with genital tuberculosis, the au-
thors concluded that although the two entities are extremely
rare, occurrence in regions with a high prevalence of tuber-
culosis may not be uncommon [12].
Genital tract TB may be suspected from the medical his-
tory, including abnormal test results such as high sedimenta-
tion rate, falsely elevated CA-125 level, and chest X-ray ﬁlm
with lesions suggestive of TB. On pelvic examination of pa-
tients,Saracogluandcolleaguesreportednormalphysicalex-
amination results (43%), adnexal mass (23.6%), myoma-like
lesion (23.6%), adnexal tenderness (4.2%), irregular uterusKemal G¨ ung¨ ord¨ uk et al. 3
(1.4%), uterine prolapse (1.4%), and cervical polyp (1.4%)
[13]. The Mantoux test (tuberculin skin test) showed a sen-
sitivity of 55% with a speciﬁcity of 80% in female genital TB
[14]. Saracoglu and colleagues found that more than 75% of
patients with genital TB had a normal chest X-ray ﬁlm. On
pelvic imaging (including hysterosalpingogram) of patients,
coronal block, ﬁmbrial block, beaded tube, hydrosalpinx,
and/or ﬁlling defects in the uterine cavity were present in
more than 70% [12]. Adnexal mass, thickened omentum,
ﬂuid in the pelvic cavity, and adhesions have been demon-
strated on pelvic ultrasound. Molecular testing, with poly-
merasechainreactionandDNAhybridization,hasbeenused
in the presumptive diagnosis of genital TB [14]. The diag-
nosis of the disease is diﬃcult. Histopathological evidence
in biopsy of premenstrual endometrial tissue or demonstra-
tion of tubercle bacilli in culture of menstrual blood or en-
dometrial currettings only can provide the certain diagno-
sis of disease. The typical lesions in genital TB are epithe-
lioid cell granulomas with or without Langerhans giant cells.
Caseation necrosis is rare and tends to be a late feature [13].
There are scant prospective data on optimal medical
management of genital TB. Treatment guidelines recom-
mend 6 months of treatment for female genital TB, provid-
ing that pyrazinamide is included for the ﬁrst 2 months of
treatment and that the organism is susceptible [15]. Surgi-
cal therapy usually consists of total abdominal hysterectomy
andbilateralsalpingo-oophorectomy.Indicationsforsurgery
include persistence of pelvic mass and recurrence of pain or
bleeding after 9 months of treatment. Surgery should be per-
formed at least 6 weeks after initiation of anti-TB therapy,
because antimicrobial treatment facilitates the surgical pro-
cedure and reduces the risk of perioperative complications
[16].
In conclusion, genital tuberculosis is rare in post-
menopausal women and responsible for only approximately
1% of postmenopausal bleeding patients. We recommend
that all patients with a positive Mantoux test result and men-
strual abnormalities undergo aggressive evaluation for geni-
tal TB.
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